Amit Munshi - 22 Apr 2024 Form 4/A - Amendment Insider Report for Zura Bio Ltd (ZURA)

Reporting relationship: Director
Issuer ticker: ZURA
Reported as of: 22 Apr 2024
Net transaction value: +$499,999
SEC form: 4/A - Amendment
Accepted by SEC: 06 Sep 2024, 17:32:12 UTC
Original report date: 24 Apr 2024
Prior SEC filing: 15 Jun 2023
Next SEC filing: 21 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Kim Davis, Attorney-in-Fact

Key filing fact

Amit Munshi filed Form 4/A - Amendment for Zura Bio Ltd (ZURA) on 06 Sep 2024.

Key facts

This page summarizes Amit Munshi's Form 4/A - Amendment filing for Zura Bio Ltd (ZURA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Sep 2024, 17:32.

Change

Previous filing in this sequence was filed on 15 Jun 2023.
Current net transaction value: +$499,999.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZURA transaction

Class A ordinary shares

Award

Transaction value: $499,999
Shares: +159,744
Change %: +26%
Price: $3.13
Shares after: 777,384
Date: 22 Apr 2024
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On April 24, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'A' instead of transaction code 'P'.

Footnote F2

These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and the Reporting Person at a purchase price of $3.13 per share.